Training in nuclear cardiology: What's new?

Hage, Fadi; Hage, Fadi G
October 2015
Journal of Nuclear Cardiology;Oct2015, Vol. 22 Issue 5, p861
Academic Journal
No abstract available.


Related Articles

  • Diagnosis, Prognosis and Therapeutic Role of Circulating miRNAs in Cardiovascular Diseases. Sayed, Ali Sheikh Md; Xia, Ke; Salma, Umme; Yang, Tianlun; Peng, Jun // Heart, Lung & Circulation;Jun2014, Vol. 23 Issue 6, p503 

    Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the world. Although much progress has been made for cardiovascular diseases in diagnosis, treatment and prognosis during the past two decades, the clinical need for a novel diagnostic biomarker and new therapeutic...

  • Results from the ACCORD Lipid Study.  // MD Conference Express;May2010, p11 

    The article discusses the results of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Study, which was presented in the American College of Cardiology (ACC) 59th Annual Scientific Session. It says that the ACCORD Lipid Study does not encourage the use of combined statin and...

  • ACC collaborates on CV database. M. I. // Medical Marketing & Media;Oct2013, Vol. 48 Issue 10, p26 

    The article reports on the collaboration of the American College of Cardiology (ACC) with a healthcare database that contains assets from the National Cardiovascular (CV) Data Registry (NCDR).

  • Trials-Based Cardiac Best Practices Stand Test of Time. Goth, Greg // Healthdatamanagement.com;6/5/2014, p4 

    The article focuses on the treatment recommendations for cardiovascular disease published by the American College of Cardiology and the American Heart Association (ACC/AHA).

  • Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population. White, Marquitta J.; Kodaman, Nuri M.; Harder, Reed H.; Asselbergs, Folkert W.; Vaughan, Douglas E.; Brown, Nancy J.; Moore, Jason H.; Williams, Scott M. // PLoS ONE;8/31/2015, Vol. 10 Issue 9, p1 

    Plasminogen activator inhibitor 1 (PAI-1), a major modulator of the fibrinolytic system, is an important factor in cardiovascular disease (CVD) susceptibility and severity. PAI-1 is highly heritable, but the few genes associated with it explain only a small portion of its variation. Studies of...

  • Looking at the Crystal Ball. Rizzo, Toni; Brugada, Josep; Vrints, Christian J. M.; Cribier, Alain; Fuster, Valentin // MD Conference Express;Oct2015, Vol. 15 Issue 28, p9 

    Reductions in cardiovascular mortality have been achieved via improved prevention, diagnosis, and treatment. However, costs have risen accordingly. A future emphasis on health promotion and disease prevention through research, education, and mitigation of disease-causing environmental factors...

  • Evaluating central blood pressure in dialysis patients. Jimi, Kanako; Tomiyama, Hirofumi; Miyaoka, Yoshitaka; Watanabe, Kanna; Kotobuki, Tomoka; Kanno, Yoshihiko // Kidney International;Jul2015, Vol. 88 Issue 1, p193 

    A letter to the editor is presented in response to the article "No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients." by C. D. Peters, K. D. Kjaergaard and J.D. Jensen in the previous issue.

  • Machine Learning Approach to Extract Diagnostic and Prognostic Thresholds: Application in Prognosis of Cardiovascular Mortality. Mena, Luis J.; Orozco, Eber E.; Felix, Vanessa G.; Ostos, Rodolfo; Melgarejo, Jesus; Maestre, Gladys E. // Computational & Mathematical Methods in Medicine;Jan2012, p1 

    Machine learning has become a powerful tool for analysing medical domains, assessing the importance of clinical parameters, and extracting medical knowledge for outcomes research. In this paper, we present a machine learning method for extracting diagnostic and prognostic thresholds, based on a...

  • Policy statement: Noninvasive CV imaging requires patient-focused approach.  // Cardiology Today;Apr2014, Vol. 17 Issue 4, p9 

    The article reports on the policy statement issued by the American College of Cardiology and 14 other related medical societies clarifying the proper use of noninvasive cardiovascular (CV) imaging, which also raised concern over the lowering use of the technology.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics